SAN FRANCISCO, Jan. 8 - Millennium Pharmaceuticals has struck a deal with Structural Genomix in which SGX will help Millennium sift through its library of drug targets, SGX said here on Tuesday.

SGX also said it has partnered with Aventis Pharmaceuticals to help it identify its own lead compounds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.